Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125667221 | 12566722 | 1 | I | 20160624 | 20160711 | 20160718 | 20160718 | EXP | FR-SA-2016SA128475 | AVENTIS | 95.00 | YR | E | F | Y | 70.00000 | KG | 20160718 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125667221 | 12566722 | 1 | SS | LASILIX | FUROSEMIDE | 1 | Oral | UNK | 0 | 20 | MG | TABLET | QD | ||||||
| 125667221 | 12566722 | 2 | SS | LASILIX | FUROSEMIDE | 1 | Oral | UNK | 0 | 40 | MG | TABLET | QD | ||||||
| 125667221 | 12566722 | 3 | PS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | UNK | 20164 | .4 | ML | QD | |||||||
| 125667221 | 12566722 | 4 | SS | PARACETAMOL SANOFI-SYNTHELABO OTC | ACETAMINOPHEN | 1 | Oral | Y | UNK | 0 | 1 | G | TID | ||||||
| 125667221 | 12566722 | 5 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | UNK | 0 | 40 | MG | GASTRO-RESISTANT TABLET | QD | ||||||
| 125667221 | 12566722 | 6 | SS | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | 25 | MG | TABLET | QD | ||||||
| 125667221 | 12566722 | 7 | SS | ZAMUDOL | TRAMADOL HYDROCHLORIDE | 1 | Oral | Y | UNK | 0 | 100 | MG | CAPSULE | BID | |||||
| 125667221 | 12566722 | 8 | SS | OXYNORM | OXYCODONE HYDROCHLORIDE | 1 | Oral | Y | UNK | 0 | 5 | MG | CAPSULE | BID | |||||
| 125667221 | 12566722 | 9 | C | LANSOYL | MINERAL OIL | 1 | Oral | 0 | 2 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125667221 | 12566722 | 1 | Urinary retention |
| 125667221 | 12566722 | 2 | Urinary retention |
| 125667221 | 12566722 | 3 | Coagulopathy |
| 125667221 | 12566722 | 4 | Pain |
| 125667221 | 12566722 | 6 | Anxiety |
| 125667221 | 12566722 | 7 | Pain |
| 125667221 | 12566722 | 8 | Pain |
| 125667221 | 12566722 | 9 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125667221 | 12566722 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125667221 | 12566722 | Cholestasis | |
| 125667221 | 12566722 | Hepatocellular injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125667221 | 12566722 | 1 | 20160622 | 20160627 | 0 | |
| 125667221 | 12566722 | 3 | 20160615 | 0 | ||
| 125667221 | 12566722 | 4 | 20160615 | 20160625 | 0 | |
| 125667221 | 12566722 | 5 | 20160614 | 0 | ||
| 125667221 | 12566722 | 6 | 20160620 | 0 | ||
| 125667221 | 12566722 | 7 | 20160622 | 20160628 | 0 | |
| 125667221 | 12566722 | 8 | 20160624 | 20160626 | 0 | |
| 125667221 | 12566722 | 9 | 20160620 | 0 |